以下文章来源于侃见财经 ，作者侃见财经 侃见财经 . 看见不一样的财经！ 这是燕之屋近五年以来首次出现"增收不增利"的情形。2021年至2023年，燕之屋的净利润分别为1.64亿 元、1.88亿元、1.97亿元，同比增速分别为34.81%、14.42%、4.93%。 与此同时，燕之屋在资本市场的表现也不尽如人意，截至4月23日收盘，其股价报6.53港元，相较于去年 7月的高点，累计跌幅已达57.4%，相较于IPO发行价（9.7港元）下跌32.7%，总市值缩水至30.4亿港元。 值得一提的是，就在前不久，燕之屋高调官宣万科集团创始人王石，成为其最新产品——"全球首款男 人燕窝"总裁碗燕的品牌代言人，引起市场关注及讨论。 这款总裁碗燕的售价高达3168元，但截至4月22日，在燕之屋天猫官方旗舰店上，这款总裁碗燕的销量 颇为惨淡，仅有65人付款。 本文转载自侃见财经 值班编辑 | 江江 视觉 | 诺言 王石没能"拯救"燕之屋。 近日，号称"燕窝第一股"的燕之屋（01497.HK）披露了最新财报，其中显示，2024年全年实现营收20.5 亿元，同比增长4.37%；净利润为1.6亿元，同比大幅下降24.18%。 | | ...

金十数据4月21日讯，记者今天了解到，截至目前，市场监管总局已完成全国在产在营保健食品生产企 业体系检查首轮全覆盖，累计完成体系检查2520家次，覆盖率达到140%，推动保健食品抽检合格率连 续5年保持在99%以上，促进整个行业食品安全管理水平明显提升。体系检查立足发现和化解风险隐 患，提升企业管理能力和水平，探索全过程、全环节监管模式，推动食品安全风险隐患防控向事前预防 型转变。 （央视新闻） 市场监管部门完成全国保健食品生产企业体系检查首轮全覆盖 ...

Investment Rating - The report indicates a positive investment outlook for the white peony health food industry, driven by increasing consumer health awareness and supportive government policies [1]. Core Insights - The white peony health food industry is in its early development stage, with significant growth potential due to rising demand from the aging population and the "silver economy" [1][35]. - White peony, as a traditional Chinese medicine, has diverse pharmacological effects, which enhances its application in health products [11][36]. - The market for white peony health foods is expected to grow from 5.25 billion RMB in 2023 to 6.79 billion RMB by 2028, with a compound annual growth rate (CAGR) of 4.61% [32]. Industry Definition - White peony health foods are defined as products primarily made from white peony that aim to regulate bodily functions and promote health rather than replace medical treatment [2][10]. Industry Classification - The white peony health food industry can be categorized into various forms, including capsules, tablets, oral liquids, and granules [3][4][5][6][7]. Industry Characteristics - The industry benefits from resource and policy support, strict regulation, and broad application prospects [8][9]. Development History - The Chinese health food industry has evolved significantly since 1996, with regulatory improvements and market optimization leading to increased maturity [12][13][14][15]. Supply Chain Analysis - The supply chain consists of upstream raw material provision, midstream production and sales, and downstream consumer sales [16]. - Ensuring high-quality raw material supply is crucial for market competitiveness [17]. - Midstream efficiency and quality control are key drivers for industry innovation [18]. Market Size and Growth - The market size for white peony health foods has grown from 4.34 billion RMB in 2019 to 5.25 billion RMB in 2023, with a CAGR of 4.87% [32][33]. - The increase in market size is attributed to rising raw material prices and strong consumer acceptance of high-quality health products [33][34]. Future Market Drivers - The aging population and government support for the silver economy are expected to significantly expand the market for white peony health foods [35]. - The diverse pharmacological properties of white peony contribute to its growing market demand [36]. Competitive Landscape - The industry is still in its early stages, with no significant brand effects or market concentration [41]. - Leading companies include Xianle Health and Tongrentang, which have extensive experience and product offerings in the health food sector [42]. Company Overview - Major players in the white peony health food market include Tongrentang, Xianle Health, and others, with varying revenue growth and profit margins [46][48].